These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 36996933)

  • 41. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases.
    Dewidar B; Mastrototaro L; Englisch C; Ress C; Granata C; Rohbeck E; Pesta D; Heilmann G; Wolkersdorfer M; Esposito I; Reina Do Fundo M; Zivehe F; Yavas A; Roden M
    EBioMedicine; 2023 Aug; 94():104714. PubMed ID: 37454552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of liquid fructose/sucrose in regulating the hepatic transcriptome in a high-fat Western diet model of NAFLD.
    Luo Y; Woodie LN; Graff EC; Zhang J; Fowler S; Wang X; Wang X; O'Neill AM; Greene MW
    J Nutr Biochem; 2023 Feb; 112():109174. PubMed ID: 36280127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle.
    Dowman JK; Hopkins LJ; Reynolds GM; Nikolaou N; Armstrong MJ; Shaw JC; Houlihan DD; Lalor PF; Tomlinson JW; Hübscher SG; Newsome PN
    Am J Pathol; 2014 May; 184(5):1550-61. PubMed ID: 24650559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.
    Tanaka Y; Nagoshi T; Takahashi H; Oi Y; Yoshii A; Kimura H; Ito K; Kashiwagi Y; Tanaka TD; Yoshimura M
    Mol Metab; 2022 Jan; 55():101411. PubMed ID: 34863940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multi-Omics Approach Reveals Dysregulation of Protein Phosphorylation Correlated with Lipid Metabolism in Mouse Non-Alcoholic Fatty Liver.
    Kim SQ; Mohallem R; Franco J; Buhman KK; Kim KH; Aryal UK
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice.
    Panzarin C; Simino LAP; Mancini MCS; Ignácio-Souza LM; Milanski M; Torsoni MA; Torsoni AS
    Mol Biol Rep; 2022 Apr; 49(4):2655-2666. PubMed ID: 35048271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different Types of Dietary Fat and Fructose Interactions Result in Distinct Metabolic Phenotypes in Male Mice.
    Shi H; Prough RA; McClain CJ; Song M
    J Nutr Biochem; 2023 Jan; 111():109189. PubMed ID: 36272691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress.
    Wei K; Wei Y; Xu W; Lu F; Ma H
    Food Funct; 2022 May; 13(10):5782-5793. PubMed ID: 35537139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction.
    Basaranoglu M; Basaranoglu G; Bugianesi E
    Hepatobiliary Surg Nutr; 2015 Apr; 4(2):109-16. PubMed ID: 26005677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.
    Lim J; Lee H; Ahn J; Kim J; Jang J; Park Y; Jeong B; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2018 Oct; 225():31-41. PubMed ID: 29958960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Niacin increases diet-induced hepatic steatosis in B6129 mice.
    Fang H; Li Z; Graff EC; McCafferty KJ; Judd RL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158731. PubMed ID: 32404278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise.
    Mouskeftara T; Deda O; Papadopoulos G; Chatzigeorgiou A; Gika H
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endurance exercise-mediated metabolic reshuffle attenuates high-caloric diet-induced non-alcoholic fatty liver disease.
    Cook JJ; Wei M; Segovia B; Cosio-Lima L; Simpson J; Taylor S; Koh Y; Kim S; Lee Y
    Ann Hepatol; 2022; 27(4):100709. PubMed ID: 35489641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.
    Li S; Liao X; Meng F; Wang Y; Sun Z; Guo F; Li X; Meng M; Li Y; Sun C
    PLoS One; 2014; 9(1):e86724. PubMed ID: 24489777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.